http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2644978-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7076dedc2d2a657bb9fccb6f5dbf0296 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-60 |
| filingDate | 2015-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0785f6d5d7406114da30b794cc69277b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ba7f0109004e34ca7c6b93c4a6a484f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_982261acde02818845f9454d68b34dd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b95905285184cb6ab856dd8130a32a24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_128cb9745c24d3fd96b1523decfb9980 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21b46b4712eb315ecc23f570454fbe93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b426f9d6b4485a0d2be002078bfc0e97 |
| publicationDate | 2018-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2644978-B1 |
| titleOfInvention | SCREENING METHOD FOR THE IDENTIFICATION OF GALANINE TYPE 2 RECEIVER AGONISTS (GALR2) AND / OR NEUROPEPTIDE TYPE Y1 RECEIVER AGONISTS AND (NPYY1R) CAPABILITIES TO PROMOTE THE INTERACTION BETWEEN GALR2 AND ASYLOR FORMATION / NPYY1R |
| abstract | Screening method for the identification of galanin type 2 receptor agonists (GALR2) and / or Y1 type neuropeptide Y (NPYY1R) agonists capable of promoting the interaction between said GALR2 and NPYY1R as well as the formation of GALR2 / heteroreceptor complexes / NPYY1R, said method characterized in that it comprises the steps of administering said agonists; and evaluate the interaction between said GALR2 and NPYY1R receptors and the formation of GALR2 / NPYY1R heteroreceptor complexes. The invention relates more particularly to a screening method in which said agonists to be administered are at least two compounds, a first GALR2 agonist, and a second NPYY1R agonist. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021245315-A1 |
| priorityDate | 2015-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 186.